Symbol Lookup

Monday April 27, 2015 6:10 PM ET. Data delayed 15 minutes.
11.62
-1.09 (-8.58%)
Bid/Lots
11.62/5
Ask/Lots
12.60/6
Open/Prev Close
12.80/12.71
Day Range
11.26-12.94
52-Week Range
7.53-17.77
Vol/Avg Daily Vol
371.8K/439.2K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
How it All Plays Out: Complementary Research on China Cord Blood, Biolase, Cara Therapeutics, Tonix, and Enzo Biochem
9:00AM ET on Friday Apr 24, 2015 by PR Newswire
Companies Mentioned: TNXP, BIOL, CO, CARA, ENZ

Editor Note: For more information about this release, please scroll to bottom.

Moments ago, Analysts Review released new research updates concerning several important developing situations including China Cord Blood Corporation (NYSE: CO), Biolase, Inc. (NASDAQ: BIOL), Cara Therapeutics, Inc. (NASDAQ: CARA), Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), and Enzo Biochem, Inc. (NYSE: ENZ). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA(R) research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

Editor Note: For more information about this release, please scroll to bottom.

Moments ago, Analysts Review released new research updates concerning several important developing situations including China Cord Blood Corporation (NYSE: CO...

Apr 15, 2015

Cara Therapeutics to Present at 3rd Conference on the Therapeutic Potential of Kappa Opioids
8:08AM ET on Wednesday Apr 15, 2015 by GlobeNewswire
Companies Mentioned: CARA

-- Company to present data from human abuse liability (HAL) study of I.V. CR845

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Chief Medical Officer Dr. Joseph Stauffer will present data from Cara's human abuse liability (HAL) study of I.V. CR845 in an oral session at the 3 Conference on the Therapeutic Potential of Kappa Opioids, held in Chapel Hill, North Carolina. CR845 is the Company's first-in-class peripherally-selective kappa opioid agonist, which has potential to be the only non-scheduled or Schedule V opioid for acute pain.

-- Company to present data from human abuse liability (HAL) study of I.V. CR845

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain ...

Apr 14, 2015

Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success
9:15AM ET on Tuesday Apr 14, 2015 by Accesswire
Companies Mentioned: CBIS, GWPH, CARA

WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD") - the non-psychoactive component of the cannabis plant - could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ: GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be possible using natural phytocannabinoids.

WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD") - the non-psychoactive component of the cannabis plant - could provide substantial health benefits. Whil...

Apr 7, 2015

Cara Therapeutics to Webcast Presentation at 14th Annual Needham Healthcare Conference
8:00AM ET on Tuesday Apr 07, 2015 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 14 Annual Needham Healthcare Conference on Tuesday, April 14, 2015, at 3:00 p.m. ET in New York City.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Der...

Peers Headlines

Today

Analyst Actions: Stemline Therapeutics Initiated With Buy And $38 Price Target At HC Wainright
5 hours ago by Midnight Trader
Companies Mentioned: STML
12:58 PM EDT, 04/27/2015 (MT Newswires) -- Stemline Therapeutics (STML) shares were initiated by HC Wainright with a buy rating and $38 price target. Price: 15.64, Change: -0.94, Percent Change: -5.67 ...

Apr 22, 2015

Analyst Actions: Stemline Therapeutics Initiated With Buy At Jefferies Group
1:05PM ET on Wednesday Apr 22, 2015 by Midnight Trader
Companies Mentioned: STML
01:05 PM EDT, 04/22/2015 (MT Newswires) -- Stemline Therapeutics (STML) shares were initiated by Jefferies Group at buy. Price: 16.65, Change: +0.27, Percent Change: +1.65 ...
Genocea Completes Enrollment in Phase 2a Human Challenge Study of GEN-004 for the Prevention of Infection by Pneumococcus
8:01AM ET on Wednesday Apr 22, 2015 by Business Wire
Companies Mentioned: GNCA

Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today reported that it has completed enrollment in its Phase 2a human challenge study of GEN-004,...

Apr 21, 2015

Sector Update: Health Care Stocks Higher Pre-Bell
8:57AM ET on Tuesday Apr 21, 2015 by Midnight Trader
Companies Mentioned: SNTA, GNCA, CORT
08:57 AM EDT, 04/21/2015 (MT Newswires) -- Top Health-care stocks: JNJ: +0.5% PFE: +0.3% ABT: flat MRK: flat AMGN: +0.8% Health-care shares were generally higher in pre-market trade Tuesday. In health-care stocks news, Synta Pharmaceuticals ...
Sector Update: Health Care
8:54AM ET on Tuesday Apr 21, 2015 by Midnight Trader
Companies Mentioned: SNTA, GNCA, CORT
08:54 AM EDT, 04/21/2015 (MT Newswires) -- Health-care shares were generally higher in pre-market trade Tuesday. In health-care stocks news, Synta Pharmaceuticals (SNTA) shares were initiated by FBR Capital with outperform rating and $6 price tar...
Analyst Actions: Genocea Biosciences Initiated With Outperform And $20 Price Target At FBR Capital
8:26AM ET on Tuesday Apr 21, 2015 by Midnight Trader
Companies Mentioned: GNCA
08:26 AM EDT, 04/21/2015 (MT Newswires) -- Genocea Biosciences (GNCA) shares were initiated by FBR Capital with outperform rating and $20 price target. Price: 12.93, Change: , Percent Change: ...
Analyst Actions: CytRx Initiated With Outperform And $8 Price Target At FBR Capital
8:23AM ET on Tuesday Apr 21, 2015 by Midnight Trader
Companies Mentioned: CYTR
08:23 AM EDT, 04/21/2015 (MT Newswires) -- CytRx (CYTR) shares were initiated by FBR Capital with outperform rating and $8 price target. Price: 5.36, Change: +0.19, Percent Change: +3.68 ...

Apr 17, 2015

Sector Update: Health Care Stocks Trimming Friday Declines; TrovaGene Jumps to 9-Year High on Lung Cancer Drug Test Results
3:57PM ET on Friday Apr 17, 2015 by Midnight Trader
Companies Mentioned: TROV, ATHX, CYTR
03:57 PM EDT, 04/17/2015 (MT Newswires) -- Top Health Care Stocks JNJ -0.23% PZE -0.60% MRK -0.61% ABT -1.68% AMGN -2.14% Health care stocks fell Friday with the NYSE Health Care Sector Index slumping 0.5% and shares of health care companies...
Sector Update: Health Care
3:55PM ET on Friday Apr 17, 2015 by Midnight Trader
Companies Mentioned: TROV, ATHX, CYTR
03:55 PM EDT, 04/17/2015 (MT Newswires) -- Health care stocks fell Friday with the NYSE Health Care Sector Index slumping 0.5% and shares of health care companies in the S&P 500 declining 0.9% as a group. In company news, TrovaGene (TROV) surged ...
Sector Update: Health Care Stocks Lower But Outperforms Most Sectors; Bristol-Myers Gains on Cancer Drug
2:20PM ET on Friday Apr 17, 2015 by Midnight Trader
Companies Mentioned: ATHX, BMY, CYTR
02:20 PM EDT, 04/17/2015 (MT Newswires) -- Top Health Care Stocks JNJ -0.33% PZE -0.88% MRK -1.12% ABT -1.94% AMGN -2.91% Health care stocks were falling Friday with the NYSE Health Care Sector Index slumping 0.8% and shares of health care c...
← Newer12Older →